Retatrutide

673K
Volume
+99X+
Growth
exploding

Turn Trends into Views🚀

Type in a topic to instantly see search volume, difficulty and related topics. All for free.

Free insights powered by
About the Topic

This is a triple agonist medication developed by Eli Lilly, designed to aid in weight loss by targeting multiple pathways. It distinguishes itself by showing promising results in recent clinical trials, with participants experiencing an average weight loss of up to 24.2%. The medication is primarily targeted at individuals seeking significant weight reduction through pharmaceutical intervention.

Retatrutide was discovered on February 3rd 2026 and it currently has a search volume of 673K with a growth of +99X+.

Key Indicators
Growth
  • Exploding
  • Regular
  • Peaked
Speed
  • Exponential
  • Constant
  • Stationary
Seasonality
  • High
  • Medium
  • Low
Volatility
  • High
  • Average
  • Low
Members Only
Try Exploding Topics Pro
Get Free, Unlimited Access for 7 Days.
Related Topics

Save this topic and build your own trend dashboard.

Available with Exploding Topics Pro, try it now.